Table 2. Detailed information on cytokine levels.
| Study group |
Cytokine (pg/ml) |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Il-1b | IL-2 | IL-4 | IL-5 | IL-6 | IL-8 | IL-10* | IL-12 | TNF-α | INF-γ* | ||
| Baseline (group 1, n=197) |
Mean±SD |
24.94±230.7 |
1.42±0.99 |
1.85±1.15 |
1.13±0.86 |
484.9±1136 |
64.00±180 |
2.17±3.31 |
11.27±75.56 |
0.88±1.32 |
1.49±2.85 |
| |
median |
0 |
1.5 |
1.8 |
1.1 |
18.0 |
10.3 |
1.85 |
1.3 |
0 |
0 |
| |
(range) |
(0–2,943.5) |
0–4.0 |
0–5.7 |
0–3.9 |
(0–5,000) |
(0–1,148) |
(0–29.1) |
(0–806.7) |
(0–6.7) |
0–11.6 |
| |
n=0 |
89 |
8 |
5 |
8 |
17 |
12 |
70 |
78 |
125 |
21 |
| |
n |
163 |
34 |
34 |
34 |
163 |
163 |
197 |
163 |
198 |
34 |
| Acceptors (group 2, n=33) |
Mean±SD |
4.53±5.65 |
0.69±1.02 |
1.17±0.99 |
0.81±0.87 |
541.0±1,423 |
24.24±18.84 |
1.92±2.2 |
2.64±2.3 |
0.78±1.36 |
0 |
| |
median |
1.95 |
0 |
1.5 |
1.0 |
49.75 |
18.95 |
1.6 |
2.6 |
0 |
0 |
| |
(range) |
(0–15) |
(0–2.6) |
(0–2.5) |
(0–2.9) |
(3.5–5,000) |
(5.0–72.9) |
(0–7.8) |
(0–5.6) |
(0–4.8) |
na |
| |
n=0 |
6 |
14 |
8 |
10 |
0 |
0 |
16 |
4 |
23 |
21 |
| |
n |
12 |
21 |
21 |
21 |
12 |
12 |
33 |
12 |
33 |
21 |
| Rejectors (group 3, n=25) |
Mean±SD |
7.86±16.21 |
1.07±1.33 |
1.15±1.28 |
1.37±1.51 |
1,772.4±2.171 |
61.87±53.78 |
5.80±7.11 |
49.54±151 |
1.21±1.88 |
24.09±68.23 |
| |
median |
1.45 |
0 |
1.2 |
1.4 |
385.8 |
47.55 |
3.65 |
2.2 |
0 |
0 |
| |
(range) |
(0–52.7) |
0–3.4 |
0–4.0 |
0–5.90 |
(0–5,000) |
(4.5–151.2) |
(0–32) |
(0–479.3) |
(0–7.5) |
0–267.9 |
| |
n=0 |
5 |
8 |
7 |
5 |
1 |
0 |
2 |
4 |
15 |
9 |
| n | 10 | 15 | 15 | 15 | 10 | 10 | 25 | 10 | 25 | 15 | |
The asterisk indicates a statistically significant difference compared to group 3. na=not applicable. n=0 means the number of samples with a cytokine level below the detection limit, which were set as zero in the statistical analysis.